In vivo, EGFR CAR-T cells also showed activity after infusion into animals bearing human lung cancer xenografts; specifically, they induced tumor regression at 25 days, as evidenced by bioluminescence imaging that showed a reduction in tumor size (155). This evidence concerns the gene EGFR and lung cancer.